Bruker Spools Up Spatial Biology Division from NanoString Technologies Canopy Biosciences Assets

Bruker has formed a new, single division out of the various spatial biology assets it has acquired over the years. Now under a single operational banner, it includes the company’s previous Bruker Spatial Genomics subsidiary—once known as Acuity Spatial Genomics—as well as the technologies obtained through its prior purchases of NanoString and Canopy Biosciences.“The formation of Bruker Spatial Biology brings together the coordination of spatial platforms that are best-in-class across spatial genomics, transcriptomics and proteomics,” Mark Munch, president of Bruker’s nanotech and scientific instruments group, said in a statement.